Related Experiment Video
Updated: May 8, 2026
04:36
Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery
Published on: April 14, 2026
Epiconjunctival mitomycin-C application for early failing filtering blebs
Aparna Rao1, Sushanta Chatterjee
1Glaucoma Services, L.V. Prasad Eye Institute , Patia, Bhubaneswar, Odisha , India.
Seminars in Ophthalmology
|August 27, 2013
Summary
Epiconjunctival Mitomycin-C (MMC) applications effectively salvaged early failing filtering blebs after glaucoma surgery. This treatment safely reduced intraocular pressure (IOP) and improved bleb characteristics, offering a viable alternative for patients.
Area of Science:
- Ophthalmology
- Glaucoma Surgery
- Ocular Pharmacology
Background:
- Glaucoma filtering surgery aims to reduce intraocular pressure (IOP).
- Early failure of filtering blebs can lead to elevated IOP and vision loss.
- Mitomycin-C (MMC) is an antifibrotic agent used in glaucoma surgery.
Purpose of the Study:
- To evaluate the efficacy of epiconjunctival Mitomycin-C (MMC) in treating early failing filtering blebs.
- To assess the impact of MMC on intraocular pressure (IOP) and bleb morphology.
Main Methods:
- Interventional case series involving patients with failing filtering blebs post-glaucoma surgery.
- Retrospective analysis of records from April 2011 to March 2012.
- Three applications of 0.04% topical MMC applied directly over the bleb at specified intervals.
Main Results:
- Eight out of ten eyes achieved complete success with a mean final IOP of 14 ± 2.9 mmHg at three months.
- Significant IOP reduction (9%-57%) observed post-MMC treatment.
- All treated blebs showed decreased vascularity and increased avascular area, indicating improved characteristics.
Conclusions:
- Epiconjunctival MMC application is a safe and effective method for salvaging early failing filtering blebs.
- This approach maximizes the antifibrotic benefits of MMC while minimizing complications.
- It presents a promising alternative for managing postoperative complications in glaucoma surgery.
Related Concept Videos
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...